吴平,李华,易吉秀,等.2种剂量131I治疗Graves病的前瞻性随机对照研究[J].第三军医大学学报,2012,34(16):1677. Wu Ping,Li Hua,Yi Jimei,et al.Therapeutic effect of 131-iodine at 2 different doses for Graves’ disease: a randomized controlled trial[J].J Third Mil Med Univ,2012,34(04):1677. [2]江学容,谭兴容,鲁远彪,等.131I治疗Graves病的远期效果随访研究[J].第三军医大学学报,2012,34(16):1689. [3]黎南中,文玉梅,程时武,等.Graves病、黑棘皮病合并B型胰岛素抵抗综合征1例[J].第三军医大学学报,2011,33(02):189. [4]马仕坤,汪荣泉.肝豆状核变性误诊为药物性肝损害1例[J].第三军医大学学报,2009,31(17):1675. [5]罗朝学,黄定德,刘开元,等.131I治疗303例Graves病早期变化分析[J].第三军医大学学报,2007,29(07):635. LUO Chao-xue,HUANG Ding-de,LIU Kai-yuan,et al.Inchoate changes in 303 cases of Graves disease treated with 131I[J].J Third Mil Med Univ,2007,29(04):635. [6]郭莲,张先祥.Graves病患者131I治疗前后血清TNF-α和TRAb水平的变化及其相关性研究[J].第三军医大学学报,2013,35(14):1528. Guo Lian,Zhang Xianxiang.Changes and correlation of serum levels of TNF-α and TRAb in patients with Graves’ disease before and after 131I treatment[J].J Third Mil Med Univ,2013,35(04):1528. [7]杨士军,崔兆辉,陆卫平.Graves病患者血清Ghrelin水平与甲状腺功能状态的关系[J].第三军医大学学报,2010,32(24):2668.
